Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial performance of ...

Cash Operating Expenses: Reduced to $16 million to $17 million for 2025, down from the previous guidance of $17 million to $19 million. Cash Operating Expenses for 2025: Totaled $3.7 million compared ...

) has been revised to $3.32 / share. This is a decrease of 22.00% from the prior estimate of $4.25 dated January 11, 2026. The price target is an average of many targets provided by analysts. The ...

Talphera Inc (NASDAQ:TLPH) has successfully onboarded five active clinical trial sites with plans to expand to seven by the end of the year, indicating progress in their ongoing registrational trial.

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings with ...

Welcome to the Talphera First Quarter 2025 Financial Results Conference Call. This call is being webcast live via the Events page of the Investors section of Talphera's website at www.talphera.com.

Talphera ( (TLPH)) has provided an announcement. At its annual meeting held on June 22, 2026, Talphera shareholders elected Marina Bozilenko, Joseph Todisco and Mark Wan as Class III directors to ...